The ethics and science of placebo-controlled trials: Assay sensitivity and the Duhem-Quine thesis

Journal of Medicine and Philosophy

Volumn 31, Issue 1, 2006, Pages 65-81

  Anderson, James A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Duhem; Equipoise; Ethics; Methodology; Placebo

Indexed keywords

PLACEBO;

AUTHOR; CLINICAL RESEARCH; CONTROLLED STUDY; ETHICS; EVIDENCE BASED MEDICINE; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MEDICAL INFORMATION; REVIEW; SCIENCE; SENSITIVITY ANALYSIS; VALIDITY;

ANALYTICAL APPROACH; BIOMEDICAL AND BEHAVIORAL RESEARCH;

DATA INTERPRETATION, STATISTICAL; DRUG EVALUATION; ETHICS, CLINICAL; ETHICS, RESEARCH; HUMANS; PLACEBOS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 32344444114     PISSN: 03605310     EISSN: None     Source Type: Journal    
DOI: 10.1080/03605310500499203     Document Type: Review

References (19)

1. Buckalew, L.W., & Coffield, K.E. (1982). An investigation of drug expectancy as a function of capsule color and size and preparation form. Journal of Clinical Psychopharmacology, 2(4), 245-248.
2. Freedman, B. (1987). Equipoise and the ethics of clinical research. New England Journal of Medicine, 317(3), 141-145.
3. Fried, C. (1974). Medical Experimentation: Personal Integrity and Social Policy. New York: American Elsevier Publishing Co., Inc.
4. Huskisson, E.C. (1974). Simple analgesics for arthritis. British Medical Journal, 4, 196-200.
5. Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St. John's Wort) in major depressive disorder: A randomized controlled trial. Journal of the American Medical Association, 287(15), 1807-1814.
6. ICH Expert Working Group. (2000). ICH Harmonised Tripartite Guideline: Choice of Control Group and Related Issues in Clinical Trials. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
7. Lasagna, L., Laties, V.G., & Dohan, J.L. (1958). Further studies on the "pharmacology" of placebo administration. Journal of Clinical Investigation, 37(4), 533-537.
8. Lucchelli, P.E., Cuttaneo, A.D., & Zattoni, J. (1978). Effect of capsule colour and order of administration of hypnotic treatments. European Journal of Clinical Pharmacology, 13, 153-155.
9. Miller, F.G., & Brody, H. (2003). A critique of clinical equipoise: therapeutic misconception in the ethics of clinical trials. Hastings Center Report, 33(1), 19-28.
10. Moerman, D. (1983). General medical effectiveness and human biology: placebo effects in the treatment of ulcer disease. Medical Anthropology Quarterly, 14(4), 3-16.
11. Ney, P.G., Collines, C., & Spensor, C. (1986). Double blind: double talk or are there ways to do better research. Medical Hypotheses, 21, 119-126.
12. Nozick, R. (1981). Philosophical Explanations. Cambridge: The Belknap Press.
13. Peirce, C.S. (1957). Essays in the Philosophy of Science. New York: Liberal Arts Press.
14. Quine, W.V.O. (1951). Two dogmas of empiricism. Philosophical Review, 60(January), 20-43.
15. Schapira, K., McClelland, H.A., Griffiths, N.R., & Newell, D.J. (1970). Study on the effects of tablet colour in the treatment of anxiety states. British Medical Journal, 1, 446-449.
16. Schindel, S. (1978). The placebo dilemma. European Journal of Clinical Pharmacology, 13, 231-235.
17. Temple, R. (1983). Difficulties in evaluating positive control trials Reprinted from The 1983 Biopharmaceutical Section Proceedings of the American Statistical Association.
18. Temple, R., & Ellenberg, S. (2000). Placebo-controlled trials and active-control trials in the evaluation of new treatments, part I: Ethical and scientific issues. Annals of Internal Medicine, 133(6), 455-463.
19. Weijer, C. (1999). Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary? Schizophrenia Research, 35(3), 211-218.